Inforsense to Distribute Pharsight's Software in China | GenomeWeb
NEW YORK (GenomeWeb News) – Pharsight has signed up Inforsense to distribute its products in China through its subsidiary in Shanghai.
Under the agreement, Inforsense will market Pharsight’s software, which is used in pharmacokinetic and pharmacodynamic analysis, reporting, archiving, and data visualization. Inforsense will distribute the software in the Chinese pharmaceutical and biotech research and development market, and conduct sales and marketing, end-user training, and maintenance and support services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.